- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 3rd, 2006
A new report warns that as nanotechnology becomes a reality, Europe must not miss the boat, and raises the alarm that the potential benefits of nanomedicine in Europe will be lost without major investment in R&D.
The report, the result of a two-year-long study conducted by the European Science Foundation (ESF), concludes that emerging nanomedicine technologies will increasingly serve as new medical tools for diagnostics and therapeutics in various areas of healthcare including drug discovery and development, drug delivery and providing targeted therapy.
|Related News Press|
New 'self-healing' gel makes electronics more flexible November 25th, 2015
Pioneering research boosts graphene revolution November 17th, 2015
Nanometrics Announces Upcoming Investor Events November 18th, 2015
Nanoparticles simplify DNA identification and quantification November 27th, 2015
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015